Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05197452 · ClinicalTrials.gov registry record · NA

Increasing COVID-19 Testing in Chicago's African American Testing Desserts

A NA study, sponsored by Rush University Medical Center.

Completed
Registry status
NA
Development phase
2,167
Enrollment target

NCT05197452 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 2,167 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05197452, a NA study, has completed, sponsored by Rush University Medical Center.

COMPLETED
Registry status
NA
Development phase
2,167 participants
Enrollment target

Study Summary

This study uses a population-based approach to increase uptake of COVID-19 testing within a highly segregated and underserved African American community in Chicago.

Interventions

  • BEHAVIORAL COVID-19 Testing

Trial Details

FieldValue
Enrollment Target 2,167 participants
Start Date 2021-03-23
Est. Completion 2022-11-18
Phase NA

Sponsor

Rush University Medical Center

320 total trials

What the Registry Record Tells You About NCT05197452

The ClinicalTrials.gov registry entry for NCT05197452 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which COVID-19 Testing is the first listed.

NCT05197452 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05197452 about?

NCT05197452 is a clinical study titled "Increasing COVID-19 Testing in Chicago's African American Testing Desserts". This study uses a population-based approach to increase uptake of COVID-19 testing within a highly segregated and underserved African American community in Chicago.

What is the current status of trial NCT05197452?

This trial is currently completed. It is a NA study. The enrollment target is 2,167 participants. The study started on 2021-03-23. Estimated completion is 2022-11-18.

What interventions are being tested in trial NCT05197452?

The interventions under investigation include: COVID-19 Testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05197452?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.